REGENERON PHARMACEUTICALS, INC. Depreciation & Amortization 2008-2026 | REGN
What is depreciation & amortization?
Depreciation and amortization represents the non-cash expense of allocating the cost of tangible and intangible assets over their useful lives.
What is REGENERON PHARMACEUTICALS, INC.'s current depreciation & amortization?
REGENERON PHARMACEUTICALS, INC. (REGN) annual depreciation & amortization for 2025 was $543.7M, a 12.59% increase from 2024. REGENERON PHARMACEUTICALS, INC. depreciation & amortization for the quarter ending March 31, 2026 was $123.2M.
What was REGENERON PHARMACEUTICALS, INC.'s depreciation & amortization in 2024?
REGENERON PHARMACEUTICALS, INC. annual depreciation & amortization for 2024 was $482.9M, a 14.70% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s depreciation & amortization in 2023?
REGENERON PHARMACEUTICALS, INC. annual depreciation & amortization for 2023 was $421.0M, a 23.32% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year depreciation & amortization CAGR?
REGENERON PHARMACEUTICALS, INC. depreciation & amortization grew at a compound annual growth rate (CAGR) of 18.18% from FY2020 to FY2025, going from $235.9M to $543.7M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $543.7M | +12.6% | 10-K |
| FY2024 | $482.9M | +14.7% | 10-K |
| FY2023 | $421.0M | +23.3% | 10-K |
| FY2022 | $341.4M | +19.3% | 10-K |
| FY2021 | $286.2M | +21.3% | 10-K |
| FY2020 | $235.9M | +12.2% | 10-K |
| FY2019 | $210.3M | +41.9% | 10-K |
| FY2018 | $148.2M | +1.9% | 10-K |
| FY2017 | $145.5M | +39.0% | 10-K |
| FY2016 | $104.7M | +39.8% | 10-K |
| FY2015 | $74.9M | +42.2% | 10-K |
| FY2014 | $52.7M | +27.9% | 10-K |
| FY2013 | $41.2M | +11.5% | 10-K |
| FY2012 | $36.9M | +18.8% | 10-K |
| FY2011 | $31.1M | +57.9% | 10-K |
| FY2010 | $19.7M | +38.6% | 10-K |
| FY2009 | $14.2M | +25.8% | 10-K |
| FY2008 | $11.3M | - | 10-K |